Tower Research Capital (TRC)’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$993K Buy
22,656
+10,346
+84% +$472K 0.03% 538
2025
Q4
$546K Sell
12,310
-10,020
-45% -$432K 0.01% 786
2025
Q3
$943K Buy
22,330
+10,115
+83% +$408K 0.03% 539
2025
Q2
$448K Sell
12,215
-12,226
-50% -$454K 0.01% 1075
2025
Q1
$931K Buy
24,441
+3,758
+18% +$140K 0.03% 530
2024
Q4
$783K Buy
20,683
+11,981
+138% +$479K 0.02% 768
2024
Q3
$354K Sell
8,702
-7,589
-47% -$287K 0.01% 1114
2024
Q2
$558K Buy
16,291
+3,232
+25% +$102K 0.01% 1249
2024
Q1
$414K Sell
13,059
-21,380
-62% -$650K 0.01% 972
2023
Q4
$1.06M Buy
34,439
+28,536
+483% +$916K 0.01% 819
2023
Q3
$196K Sell
5,903
-24,769
-81% -$791K 0.01% 1447
2023
Q2
$941K Buy
30,672
+20,295
+196% +$586K 0.03% 550
2023
Q1
$284K Buy
10,377
+3,762
+57% +$105K 0.01% 1170
2022
Q4
$185K Sell
6,615
-10,015
-60% -$302K 0.01% 1355
2022
Q3
$490K Sell
16,630
-4,228
-20% -$133K 0.01% 1160
2022
Q2
$588K Buy
20,858
+12,581
+152% +$358K 0.01% 1031
2022
Q1
$258K Sell
8,277
-17,809
-68% -$525K ﹤0.01% 1558
2021
Q4
$772K Buy
26,086
+7,034
+37% +$205K 0.01% 844
2021
Q3
$571K Sell
19,052
-13,072
-41% -$450K 0.01% 890
2021
Q2
$1.17M Sell
32,124
-10,212
-24% -$379K 0.03% 552
2021
Q1
$1.55M Buy
42,336
+21,022
+99% +$774K 0.03% 573
2020
Q4
$774K Buy
21,314
+11,292
+113% +$383K 0.02% 665
2020
Q3
$300K Sell
10,022
-13,586
-58% -$424K ﹤0.01% 2189
2020
Q2
$702K Buy
23,608
+5,957
+34% +$176K 0.03% 759
2020
Q1
$468K Buy
17,651
+17,433
+7,997% +$661K 0.03% 450
2019
Q4
$9K Sell
218
-2,270
-91% -$96.1K ﹤0.01% 2396
2019
Q3
$104K Sell
2,488
-11,469
-82% -$447K 0.01% 1326
2019
Q2
$513K Buy
13,957
+559
+4% +$20.4K 0.03% 455
2019
Q1
$511K Buy
13,398
+2,075
+18% +$76.9K 0.03% 591
2018
Q4
$398K Sell
11,323
-8,215
-42% -$285K 0.03% 484
2018
Q3
$640K Sell
19,538
-18,528
-49% -$590K 0.05% 376
2018
Q2
$1.18M Buy
38,066
+13,700
+56% +$392K 0.07% 293
2018
Q1
$659K Buy
24,366
+23,940
+5,620% +$638K 0.06% 341
2017
Q4
$12K Buy
426
+204
+92% +$5.89K ﹤0.01% 2443
2017
Q3
$7K Buy
+222
New +$7.11K ﹤0.01% 3208
2017
Q2
Sell
-371
Closed -$12K 3221
2017
Q1
$12K Sell
371
-42
-10% -$1.35K ﹤0.01% 1646
2016
Q4
$13K Sell
413
-11,618
-97% -$359K ﹤0.01% 2479
2016
Q3
$427K Buy
12,031
+7,421
+161% +$264K 0.04% 202
2016
Q2
$156K Buy
4,610
+1,034
+29% +$34.5K 0.01% 823
2016
Q1
$126K Buy
3,576
+3,276
+1,092% +$107K 0.02% 439
2015
Q4
$10K Sell
300
-52
-15% -$1.8K ﹤0.01% 2131
2015
Q3
$12K Sell
352
-993
-74% -$34.9K ﹤0.01% 2164
2015
Q2
$46K Buy
+1,345
New +$49.4K ﹤0.01% 1432
2014
Q4
Sell
-178
Closed -$6K 4497
2014
Q3
$6K Sell
178
-5,925
-97% -$218K ﹤0.01% 3172
2014
Q2
$225K Buy
+6,103
New +$218K 0.03% 549
2014
Q1
Sell
-1,431
Closed -$43K 4785
2013
Q4
$43K Sell
1,431
-1,866
-57% -$59.1K 0.01% 1523
2013
Q3
$99K Buy
3,297
+3,241
+5,788% +$98.6K 0.01% 1304
2013
Q2
$2K Buy
+56
New +$1.84K ﹤0.01% 3495

Other funds holding OHI

Tower Research Capital (TRC)'s OHI Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Omega Healthcare (OHI) stake by 84% in Q1 2026, buying an estimated $472K and bringing the position to 22,656 shares worth $993K. The position accounts for 0.03% of the portfolio, ranked #538.

Tower Research Capital (TRC) first reported a position in OHI in Q2 2013 and has held it in 48 quarters since. The position peaked at $1.55M in Q1 2021. 743 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Tower Research Capital (TRC) held 22,656 shares of Omega Healthcare worth $993K as of Q1 2026.
  • Tower Research Capital (TRC) bought 10,346 Omega Healthcare shares in Q1 2026, an estimated $472K.
  • Omega Healthcare made up 0.03% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #538 holding.
  • Tower Research Capital (TRC) first reported a position in Omega Healthcare in Q2 2013 and has held it in 48 quarters since.
  • Tower Research Capital (TRC)'s Omega Healthcare position peaked at $1.55M in Q1 2021.
  • 743 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.